Vera Therapeutics, Inc. (VERA) stock

VERANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30

$28.10−0.94 (-3.24%)

Close on Nov 13, 2026Market cap $2.02BP/E –Yield –

Vera Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	67.9%	–

See a number that looks wrong?